Kyongok Park1, Seonhye Lee2, JeongEun Yang3, Taekwon Song3, Gwi-Ryung Son Hong3. 1. Department of Nursing, Gangneung-Wonju National University, Wonju, Republic of Korea. 2. Department of Nursing, Gyeongnam National University of Science and Technology, Jinju-si, Republic of Korea. 3. College of Nursing, Hanyang University, Seoul, Republic of Korea.
Abstract
BACKGROUND: The main objective of this study was to conduct a meta-analysis to identify the effects of reminiscence therapy in people with dementia (PWD). METHODS: A systematic search of randomized controlled trials (RCTs) was conducted using bibliographic databases. A total of 157 original published studies were identified in the search, and 24 complete articles were included in the final review to check for the level of evidence. Two of the study authors independently assessed the quality of the included studies using the "Risk of Bias" (ROB) tool developed by the Cochrane Collaboration. Depression, quality of life, and behavioral and psychological symptoms of dementia (BPSD) were selected to measure the effect of reminiscence therapy. To determine the effects of reminiscence therapy on these variables, each individual study was analyzed using Comprehensive Meta-Analysis Software® (Biostat, Englewood, NJ, USA). RESULTS: The overall effect size was presented using standardized mean differences (SMDs) and 95% confidence intervals. Cohen's d effect size for depression was -0.541 (95% CI: -0.847 to -0.234, Z = -3.730, p<0.001), indicating that depression was significantly reduced in the reminiscence group compared to the control group. Increased quality of life and decreased BPSD were also found in the reminiscence group compared to the control group. CONCLUSION: Reminiscence therapy has a moderate effect on depression and can be broadly used to decrease depression as an alternative to antipsychotics, which can have harmful side effects and high cost.
BACKGROUND: The main objective of this study was to conduct a meta-analysis to identify the effects of reminiscence therapy in people with dementia (PWD). METHODS: A systematic search of randomized controlled trials (RCTs) was conducted using bibliographic databases. A total of 157 original published studies were identified in the search, and 24 complete articles were included in the final review to check for the level of evidence. Two of the study authors independently assessed the quality of the included studies using the "Risk of Bias" (ROB) tool developed by the Cochrane Collaboration. Depression, quality of life, and behavioral and psychological symptoms of dementia (BPSD) were selected to measure the effect of reminiscence therapy. To determine the effects of reminiscence therapy on these variables, each individual study was analyzed using Comprehensive Meta-Analysis Software® (Biostat, Englewood, NJ, USA). RESULTS: The overall effect size was presented using standardized mean differences (SMDs) and 95% confidence intervals. Cohen's d effect size for depression was -0.541 (95% CI: -0.847 to -0.234, Z = -3.730, p<0.001), indicating that depression was significantly reduced in the reminiscence group compared to the control group. Increased quality of life and decreased BPSD were also found in the reminiscence group compared to the control group. CONCLUSION: Reminiscence therapy has a moderate effect on depression and can be broadly used to decrease depression as an alternative to antipsychotics, which can have harmful side effects and high cost.
Authors: Tiago Coelho; Cátia Marques; Daniela Moreira; Maria Soares; Paula Portugal; António Marques; Ana Rita Ferreira; Sónia Martins; Lia Fernandes Journal: Int J Environ Res Public Health Date: 2020-12-12 Impact factor: 3.390
Authors: Sietske A M Sikkes; Yi Tang; Roos J Jutten; Linda M P Wesselman; Lyn S Turkstra; Henry Brodaty; Linda Clare; Erin Cassidy-Eagle; Kay L Cox; Gaël Chételat; Sophie Dautricourt; Klodian Dhana; Hiroko Dodge; Rose-Marie Dröes; Benjamin M Hampstead; Thomas Holland; Amit Lampit; Kate Laver; Antoine Lutz; Nicola T Lautenschlager; Susan M McCurry; Franka J M Meiland; Martha Clare Morris; Kimberly D Mueller; Ruth Peters; Gemma Ridel; Aimee Spector; Jenny T van der Steen; Jeanette Tamplin; Zara Thompson; Alex Bahar-Fuchs Journal: Alzheimers Dement Date: 2020-11-20 Impact factor: 21.566